Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 24, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Limei Wu1, Yutong Zhang1, Zhimin Wang1
1Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, Hunan, 410082, P. R. China.
Aptamers, or "chemical antibodies," offer precise cancer cell analysis and treatment. These DNA/RNA molecules provide advantages like easy synthesis and high selectivity for advanced cancer theranostics.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: